Comment on "Effectiveness of Anti-Calcitonin Gene-Related Peptide Medication in Vestibular Migraine: A Retrospective Cohort Study in an Asian Population" (vol 39, pg 107, 2025)

被引：0
|
作者：
Zhou, Xin [1 ]
Zhang, Aiping [2 ]
Lin, Riyang [2 ,3 ]
机构：
[1] Tianshui Wulin St Community Heal Care Ctr, 4 Yesutang Long, Hangzhou 310005, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Dept Tradit Chinese Med, Hangzhou TCM Hosp, 453 Tiyuchang Rd, Hangzhou 310007, Zhejiang, Peoples R China
[3] Key Lab Kidney Dis Prevent & Control Technol, Hangzhou, Zhejiang, Peoples R China
来源：
CNS DRUGS | 2025年 / 39卷 / 03期
关键词：
D O I：
10.1007/s40263-024-01147-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：337 / 337
页数：1
相关论文
共 50 条
  • [1] Comment on "Effectiveness of Anti-Calcitonin Gene-Related Peptide Medication in Vestibular Migraine: A Retrospective Cohort Study in an Asian Population"
    Zhou, Xin
    Zhang, Aiping
    Lin, Riyang
    CNS DRUGS, 2025, 39 (01) : 107 - 108
  • [2] Effectiveness of Anti-Calcitonin Gene-Related Peptide Medication in Vestibular Migraine: A Retrospective Cohort Study in an Asian Population
    Kouga, Teppei
    Miwa, Toru
    Sunami, Kishiko
    Itoh, Yoshiaki
    CNS DRUGS, 2024, 38 (08) : 637 - 648
  • [3] Author's Reply to Zhou et al: Comment on "Effectiveness of Anti-Calcitonin Gene-Related Peptide Medication in Vestibular Migraine: A Retrospective Cohort Study in an Asian Population"
    Miwa, Toru
    CNS DRUGS, 2025, 39 (01) : 109 - 110
  • [4] Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for the Treatment of Vestibular Migraine
    Russo, C.
    Braca, S.
    Sacca, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 685 - 685
  • [5] Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study
    Russo, Cinzia Valeria
    Sacca, Francesco
    Braca, Simone
    Sansone, Mattia
    Miele, Angelo
    Stornaiuolo, Antonio
    De Simone, Roberto
    CEPHALALGIA, 2023, 43 (04)
  • [6] Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine
    de Dios, Anna
    Pages-Puigdemont, Neus
    Ojeda, Sergio
    Riera, Pau
    Pelegrin, Rebeca
    Morollon, Noemi
    Belvis, Robert
    Real, Jordi
    Masip, Montserrat
    HEADACHE, 2025, 65 (01): : 24 - 34
  • [7] Effectiveness and Tolerability of Anti-Calcitonin Gene-Related Peptide Therapy for Migraine and Other Chronic Headaches in Adolescents and Young Adults: A Retrospective Study in the USA
    Bandatmakur, Anjaneya Shankar Madhav
    Dave, Pooja
    Kerr, Melissa
    Brunick, Colin
    Wen, Sijin
    Hansen, Nicholas
    BRAIN SCIENCES, 2024, 14 (09)
  • [8] Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Clinical Pharmacokinetics
    Jankovic, Slobodan M.
    Jankovic, Snezana V.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (03) : 277 - 293
  • [9] Use of Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies in Pediatric Migraine Prevention
    Suleman, Saher
    Chow, Clara
    Rastogi, Reena Gogia
    NEUROLOGY, 2021, 96 (15)
  • [10] Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Clinical Pharmacokinetics
    Slobodan M. Janković
    Snežana V. Janković
    European Journal of Drug Metabolism and Pharmacokinetics, 2024, 49 : 277 - 293
12345